New Delhi, Home drug majors Solar Pharma, Lupin and Dr Reddy’s Laboratories are recalling medicine within the US market as a consequence of manufacturing points and product combine up, based on the US well being regulator.
As per the most recent Enforcement Report of US Meals and Drug Administration , the Mumbai-headquartered Solar Pharmaceutical Industries is recalling 5,448 bottles of a generic treatment within the US.
Princeton-based Solar Pharmaceutical Industries Inc is recalling the affected lot of Lisdexamfetamine Dimesylate capsules as a consequence of “Failed Dissolution Specs”, the US well being regulator said.
The treatment is used to deal with consideration deficit hyperactivity dysfunction .
The drug agency initiated the Class II recall within the US on June 16 this 12 months, it added.
One other Mumbai-based drug maker Lupin is recalling 58,968 bottles of a generic mixture treatment used to deal with hypertension.
Naples-based Lupin Prescription drugs Inc is recalling Lisinopril and Hydrochlorothiazide tablets . The affected lot was manufactured on the firm’s Nagpur-based manufacturing facility.
As per the USFDA, the corporate initiated the Class II recall on June 20 as a consequence of “Product Combine Up”.
This product is being recalled due to a criticism obtained {that a} sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a international pill recognized as atazanavir and ritonavir pill 300mg/100mg, the US well being regulator said.
In one other submitting, the US well being regulator mentioned that Dr Reddy’s Laboratories is recalling 1,476 bottles of Omeprazole Delayed-release capsules.
The treatment is used to deal with sure abdomen and esophagus issues.
Princeton-based Dr. Reddy’s Laboratories, Inc initiated the Class II recall on June 30, 2025, USFDA said.
The affected lot was produced on the firm’s Bachupally -based manufacturing facility.
The recall is because of the presence of international tablets/capsules, USFDA mentioned.
It’s because of the presence of international Divalproex Sodium extended-release 250mg tablets in a bottle of omeprazole capsules, it added.
As per the USFDA, a Class-II recall is initiated when the usage of, or publicity to, a violative product might result in non permanent or medically reversible well being penalties, or when the probability of great hostile well being outcomes is minimal.
This text was generated from an automatic information company feed with out modifications to textual content.